Reimagining Medicine Q2 2023 Results slide image

Reimagining Medicine Q2 2023 Results

Company overview Financial review Conclusions Appendix References Harry Kirsch Chief Financial Officer Financial review and 2023 guidance 18 Investor Relations | Q2 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation